These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The natural history of renal artery stenosis: who should be evaluated for suspected ischemic nephropathy? Greco BA; Breyer JA Semin Nephrol; 1996 Jan; 16(1):2-11. PubMed ID: 8720081 [TBL] [Abstract][Full Text] [Related]
6. Ischemic nephropathy: where are we now? Textor SC J Am Soc Nephrol; 2004 Aug; 15(8):1974-82. PubMed ID: 15284283 [TBL] [Abstract][Full Text] [Related]
7. Temporary renal ischemia during nephron sparing surgery is associated with short-term but not long-term impairment in renal function. Yossepowitch O; Eggener SE; Serio A; Huang WC; Snyder ME; Vickers AJ; Russo P J Urol; 2006 Oct; 176(4 Pt 1):1339-43; discussion 1343. PubMed ID: 16952626 [TBL] [Abstract][Full Text] [Related]
8. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists? Bauer JH; Reams GP J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071 [TBL] [Abstract][Full Text] [Related]
9. [Ischemic renal disease: revascularization or conservative treatment?]. Rodríguez Jornet A; Ibeas J; Ribera L; Real J; Perendreu J; Falcó J; Vallespín J; Allegué N; Giménez Gaibar A; García García M Nefrologia; 2005; 25(3):258-68. PubMed ID: 16053007 [TBL] [Abstract][Full Text] [Related]
10. [Regeneration following acute kidney damage]. De Broe ME Verh K Acad Geneeskd Belg; 1998; 60(4):359-83; discussion 383-4. PubMed ID: 9883082 [TBL] [Abstract][Full Text] [Related]
11. [The role of endothelial progenitor cells in renal disease]. Lazzeri E; Angelotti ML; Ballerini L; Becherucci F; Mazzinghi B; Parente E; Ronconi E; Sagrinati C; Romagnani P; Lasagni L G Ital Nefrol; 2008; 25(5):537-46. PubMed ID: 18828116 [TBL] [Abstract][Full Text] [Related]
12. The role of endothelial progenitor cells in acute kidney injury. Becherucci F; Mazzinghi B; Ronconi E; Peired A; Lazzeri E; Sagrinati C; Romagnani P; Lasagni L Blood Purif; 2009; 27(3):261-70. PubMed ID: 19218794 [TBL] [Abstract][Full Text] [Related]
13. [Vascular mechanisms of renal fibrosis. Vasculonephropathies and arterial hypertension]. Meyrier A Bull Acad Natl Med; 1999; 183(1):33-45; discussion 45-6. PubMed ID: 10371763 [TBL] [Abstract][Full Text] [Related]
14. Vasculoprotective and cardioprotective mechanisms of angiotensin-converting enzyme inhibition: the homeostatic balance between angiotensin II and nitric oxide. Gibbons GH Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-18-25. PubMed ID: 9422848 [TBL] [Abstract][Full Text] [Related]
15. [Causes of late renal transplant dysfunction]. Szabó A; Müller V Orv Hetil; 2002 Dec; 143(51):2811-9. PubMed ID: 12638307 [TBL] [Abstract][Full Text] [Related]
16. Disorders of body fluid balance: a new look into the mechanisms of disease. Plante GE; Chakir M; Lehoux S; Lortie M Can J Cardiol; 1995 Oct; 11(9):788-802. PubMed ID: 7585278 [TBL] [Abstract][Full Text] [Related]
17. Ischemic acute renal failure in the rat: effects of L-arginine and superoxide dismutase on renal function. Schramm L; Seibold A; Schneider R; Zimmermann J; Netzer KO; Wanner C J Nephrol; 2008; 21(2):229-35. PubMed ID: 18446718 [TBL] [Abstract][Full Text] [Related]
18. The pathophysiologic basis for blocking the renin-angiotensin system in hypertensive patients with renal disease. Raij L Am J Hypertens; 2005 Apr; 18(4 Pt 2):95S-99S. PubMed ID: 15837551 [TBL] [Abstract][Full Text] [Related]